Key facts
- This page summarizes Glen A. Farmer's Form 4 filing for Immune Therapeutics, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 22 Feb 2023, 18:00.
Glen A. Farmer - 10 Feb 2023 Form 4 Insider Report for Immune Therapeutics, Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 10 Feb 2023
- Net transaction value
- +$18,405
- SEC form
- 4
- Accepted by SEC
- 22 Feb 2023, 18:00:20 UTC
- Prior SEC filing
- 15 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Glen A. Farmer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Glen A. Farmer filed Form 4 for Immune Therapeutics, Inc. on 22 Feb 2023.
Change
- Previous filing in this sequence was filed on 15 Dec 2022.
- Current net transaction value: +$18,405.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMUN
transaction
Common Stock
Purchase
- Transaction value
- $18,405
- Shares
- +409,000
- Change %
- Price
- $0.0450
- Shares after
- 409,000
- Date
- 10 Feb 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.